ARTICLE | Company News
Epitomics cancer, antibodies news
August 23, 2010 7:00 AM UTC
Epitomics spun out newco Apexigen Inc. (Burlingame, Calif.) to focus on developing and commercializing humanized mAbs to treat cancer and immune disorders. Epitomics granted Apexigen exclusive, world...